GCM
MD icon

Gallacher Capital Management’s Pediatrix Medical MD Stock Holding History

Gallacher Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
8,393
-1,997
-19% -$45.4K 0.12% 250
2026
Q1 		$222K Buy
+10,390
New +$216K 0.09% 280

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Gallacher Capital Management's MD Position: Q2 2026 in Review

Gallacher Capital Management reduced its Pediatrix Medical (MD) stake by 19% in Q2 2026, selling an estimated $45.4K and leaving 8,393 shares worth $213K. The position accounts for 0.12% of the portfolio, ranked #250.

Gallacher Capital Management first reported a position in MD in Q1 2026 and has held it in 2 quarters since. The position peaked at $222K in Q1 2026. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Gallacher Capital Management held 8,393 shares of Pediatrix Medical worth $213K as of Q2 2026.
  • Gallacher Capital Management sold 1,997 Pediatrix Medical shares in Q2 2026, an estimated $45.4K.
  • Pediatrix Medical made up 0.12% of Gallacher Capital Management's portfolio in Q2 2026, its #250 holding.
  • Gallacher Capital Management first reported a position in Pediatrix Medical in Q1 2026 and has held it in 2 quarters since.
  • Gallacher Capital Management's Pediatrix Medical position peaked at $222K in Q1 2026.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.